Aytu BioPharma appoints Vivian Liu to board of directors effective July 1, 2022

AYTU BIOPHARMA, INC

Vivian Liu appointed to Aytu's board as independent director and member of Nominating & Corporate Governance Committee.
Liu receives initial grant of 6,500 restricted shares; one-third vests July 1, 2023, remainder over eight quarters.
Liu previously served as President/CEO/CFO of Innovus Pharmaceuticals (acquired by Aytu in Feb 2020) and other biopharma firms.
CEO Josh Disbrow highlights Liu's clinical and corporate development expertise to support company's growth strategy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Vivian Liu

Director

AYTU · AYTU BIOPHARMA, INC

Effective: 2022-07-01
Filed: June 29, 2022, 7:59 PM ET

On June 24 2022, the Board of Directors of Aytu BioPharma, Inc. (the “Company”) appointed Vivian Liu to the Board of Directors, effective July 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vivian Liu was appointed as Director at AYTU BIOPHARMA, INC.

Action: appointed
Role: Director

Exact text from the filing

On June 24 2022, the Board of Directors of Aytu BioPharma, Inc. (the “Company”) appointed Vivian Liu to the Board of Directors, effective July 1, 2022.

View on SEC.gov

AYTU BIOPHARMA, INC filing history →

Source: SEC EDGAR

accession 0001558370-22-010401

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.